These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20694687)

  • 1. Ligand-based nuclear magnetic resonance screening techniques.
    Viegas A; Macedo AL; Cabrita EJ
    Methods Mol Biol; 2009; 572():81-100. PubMed ID: 20694687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR techniques for characterization of ligand binding: utility for lead generation and optimization in drug discovery.
    Moore JM
    Biopolymers; 1999; 51(3):221-43. PubMed ID: 10516573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using NMR for ligand discovery and optimization.
    Villar HO; Yan J; Hansen MR
    Curr Opin Chem Biol; 2004 Aug; 8(4):387-91. PubMed ID: 15288248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of 19F NMR spectroscopy to screen chemical libraries for ligands that bind to proteins.
    Tengel T; Fex T; Emtenas H; Almqvist F; Sethson I; Kihlberg J
    Org Biomol Chem; 2004 Mar; 2(5):725-31. PubMed ID: 14985813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystallography, NMR and virtual screening: integrated tools for drug discovery.
    Muchmore SW; Hajduk PJ
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):544-9. PubMed ID: 12951817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using NMR solvent water relaxation to investigate metalloenzyme-ligand binding interactions.
    Leung IK; Flashman E; Yeoh KK; Schofield CJ; Claridge TD
    J Med Chem; 2010 Jan; 53(2):867-75. PubMed ID: 20025281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR-based analysis of protein-ligand interactions.
    Cala O; Guillière F; Krimm I
    Anal Bioanal Chem; 2014 Feb; 406(4):943-56. PubMed ID: 23591643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based screening using X-ray crystallography and NMR spectroscopy.
    Jhoti H; Cleasby A; Verdonk M; Williams G
    Curr Opin Chem Biol; 2007 Oct; 11(5):485-93. PubMed ID: 17851109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TINS, target immobilized NMR screening: an efficient and sensitive method for ligand discovery.
    Vanwetswinkel S; Heetebrij RJ; van Duynhoven J; Hollander JG; Filippov DV; Hajduk PJ; Siegal G
    Chem Biol; 2005 Feb; 12(2):207-16. PubMed ID: 15734648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid acquisition of 1H and 19F NMR experiments for direct and competition ligand-based screening.
    Dalvit C; Gossert AD; Coutant J; Piotto M
    Magn Reson Chem; 2011 Apr; 49(4):199-202. PubMed ID: 21387401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR fragment screening: Advantages and applications.
    Schade M
    IDrugs; 2006 Feb; 9(2):110-3. PubMed ID: 16523400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aroma WaterLOGSY: a fast and sensitive screening tool for drug discovery.
    Hu J; Eriksson PO; Kern G
    Magn Reson Chem; 2010 Dec; 48(12):909-11. PubMed ID: 21038321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A strategy for high-throughput assay development using leads derived from nuclear magnetic resonance-based screening.
    Hajduk PJ; Betz SF; Mack J; Ruan X; Towne DL; Lerner CG; Beutel BA; Fesik SW
    J Biomol Screen; 2002 Oct; 7(5):429-32. PubMed ID: 14599358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening protein-small molecule interactions by NMR.
    Davis B
    Methods Mol Biol; 2013; 1008():389-413. PubMed ID: 23729260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Water-based ligand screening for paramagnetic metalloproteins.
    Bertini I; Fragai M; Luchinat C; Talluri E
    Angew Chem Int Ed Engl; 2008; 47(24):4533-7. PubMed ID: 18465767
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of NMR screening techniques for observing ligand binding with a protein receptor.
    Shimotakahara S; Furihata K; Tashiro M
    Magn Reson Chem; 2005 Jan; 43(1):69-72. PubMed ID: 15476289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.